CONTRIBUTO SPERIMENTALE SULL'IMPIEGO DEL CISPLATINO IN ONCOLOGIA

Translated title of the contribution: Experimental contribution to the use of cisplatinum in oncology

A. Scanni, M. Tomirotti, D. Campolunghi, M. Biraghi, G. Curtarelli

Research output: Contribution to journalArticle

Abstract

Twenty-nine patients affects affected by ovarian (9 cases), head and neck (13), and miscellaneous (7) neoplasms were treated with Cisplatinum. Most cases had been previously treated with different drugs. Complete and partial remission achieved significant results in 3 ovarian patients. In the patients with head and neck tumor no complete remission and 4 partial remissions were obtained. These observations confirm that Cisplatinum may be a useful drug in cancer chemotherapy.

Translated title of the contributionExperimental contribution to the use of cisplatinum in oncology
Original languageItalian
Pages (from-to)851-857
Number of pages7
JournalMinerva Medica
Volume76
Issue number17-18
Publication statusPublished - 1985

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Experimental contribution to the use of cisplatinum in oncology'. Together they form a unique fingerprint.

  • Cite this

    Scanni, A., Tomirotti, M., Campolunghi, D., Biraghi, M., & Curtarelli, G. (1985). CONTRIBUTO SPERIMENTALE SULL'IMPIEGO DEL CISPLATINO IN ONCOLOGIA. Minerva Medica, 76(17-18), 851-857.